Northwest Biotherapeutics Stock Market Value
| NWBO Stock | USD 0.27 0.01 3.85% |
| Symbol | Northwest |
Northwest Biotherapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Northwest Biotherapeutics' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Northwest Biotherapeutics.
| 11/27/2024 |
| 12/27/2024 |
If you would invest 0.00 in Northwest Biotherapeutics on November 27, 2024 and sell it all today you would earn a total of 0.00 from holding Northwest Biotherapeutics or generate 0.0% return on investment in Northwest Biotherapeutics over 30 days. Northwest Biotherapeutics is related to or competes with Celldex Therapeutics, CEL SCI, Morningstar Unconstrained, Thrivent High, Via Renewables, T Rowe, and 70082LAB3. Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the Unite... More
Northwest Biotherapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Northwest Biotherapeutics' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Northwest Biotherapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 22.79 | |||
| Value At Risk | (6.67) | |||
| Potential Upside | 6.67 |
Northwest Biotherapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Northwest Biotherapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Northwest Biotherapeutics' standard deviation. In reality, there are many statistical measures that can use Northwest Biotherapeutics historical prices to predict the future Northwest Biotherapeutics' volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.34) | |||
| Total Risk Alpha | (0.50) | |||
| Treynor Ratio | (0.20) |
Northwest Biotherapeutics Backtested Returns
Northwest Biotherapeutics has Sharpe Ratio of -0.0455, which conveys that the firm had a -0.0455% return per unit of risk over the last 3 months. Northwest Biotherapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Northwest Biotherapeutics' Risk Adjusted Performance of (0.04), standard deviation of 4.11, and Mean Deviation of 2.98 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 1.4, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Northwest Biotherapeutics will likely underperform. At this point, Northwest Biotherapeutics has a negative expected return of -0.19%. Please make sure to verify Northwest Biotherapeutics' treynor ratio, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to decide if Northwest Biotherapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.34 |
Poor reverse predictability
Northwest Biotherapeutics has poor reverse predictability. Overlapping area represents the amount of predictability between Northwest Biotherapeutics time series from 27th of November 2024 to 12th of December 2024 and 12th of December 2024 to 27th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Northwest Biotherapeutics price movement. The serial correlation of -0.34 indicates that nearly 34.0% of current Northwest Biotherapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.34 | |
| Spearman Rank Test | -0.44 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Northwest Biotherapeutics lagged returns against current returns
Autocorrelation, which is Northwest Biotherapeutics otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Northwest Biotherapeutics' otc stock expected returns. We can calculate the autocorrelation of Northwest Biotherapeutics returns to help us make a trade decision. For example, suppose you find that Northwest Biotherapeutics has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Northwest Biotherapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Northwest Biotherapeutics otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Northwest Biotherapeutics otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Northwest Biotherapeutics otc stock over time.
Current vs Lagged Prices |
| Timeline |
Northwest Biotherapeutics Lagged Returns
When evaluating Northwest Biotherapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Northwest Biotherapeutics otc stock have on its future price. Northwest Biotherapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Northwest Biotherapeutics autocorrelation shows the relationship between Northwest Biotherapeutics otc stock current value and its past values and can show if there is a momentum factor associated with investing in Northwest Biotherapeutics.
Regressed Prices |
| Timeline |
Pair Trading with Northwest Biotherapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Northwest Biotherapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Northwest Biotherapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Northwest OTC Stock
| 0.48 | EPRX | Eupraxia Pharmaceuticals | PairCorr |
| 0.36 | FRTX | Fresh Tracks Therapeutics | PairCorr |
| 0.36 | GRCE | Grace Therapeutics, Symbol Change | PairCorr |
| 0.34 | FBIOP | Fortress Biotech Pref | PairCorr |
| 0.31 | EVLO | Evelo Biosciences | PairCorr |
The ability to find closely correlated positions to Northwest Biotherapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Northwest Biotherapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Northwest Biotherapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Northwest Biotherapeutics to buy it.
The correlation of Northwest Biotherapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Northwest Biotherapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Northwest Biotherapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Northwest Biotherapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Northwest OTC Stock
Northwest Biotherapeutics financial ratios help investors to determine whether Northwest OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Northwest with respect to the benefits of owning Northwest Biotherapeutics security.